{"id":"NCT04193202","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"Efficacy and Safety of Gefapixant (MK-7264) in Adult Participants With Recent Onset Chronic Cough (MK-7264-043)","officialTitle":"A Phase 3b Randomized, Double-blind, Placebo Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Gefapixant in Adult Participants With Recent Onset Chronic Cough","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-05-21","primaryCompletion":"2021-10-19","completion":"2021-11-03","firstPosted":"2019-12-10","resultsPosted":"2022-10-14","lastUpdate":"2023-05-16"},"enrollment":419,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Cough"],"interventions":[{"type":"DRUG","name":"Gefapixant","otherNames":["MK-7264"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Gefapixant","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the efficacy and safety of gefapixant in participants with recent onset chronic cough (duration \\>8 weeks after onset of cough symptoms) for \\<12 months and a diagnosis of refractory or unexplained chronic cough. The primary hypothesis is that gefapixant is superior to placebo in improving cough-related quality of life measured as change from baseline in the Leicester Cough Questionnaire (LCQ) total score at Week 12.","primaryOutcome":{"measure":"Change From Baseline in the Leicester Cough Questionnaire (LCQ) Total Score at Week 12","timeFrame":"Baseline, Week 12","effectByArm":[{"arm":"Gefapixant","deltaMin":4.34,"sd":null},{"arm":"Placebo","deltaMin":3.59,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.034"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":12},"locations":{"siteCount":91,"countries":["United States","Canada","Colombia","Germany","Guatemala","Peru","Poland","Russia","South Korea","Spain","Ukraine","United Kingdom"]},"refs":{"pmids":["36879087"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":206},"commonTop":["Dysgeusia","Headache","Ageusia","Hypogeusia"]}}